Saltar al contenido
Merck

Bacteria-induced uroplakin signaling mediates bladder response to infection.

PLoS pathogens (2009-05-05)
Praveen Thumbikat, Ruth E Berry, Ge Zhou, Benjamin K Billips, Ryan E Yaggie, Tetiana Zaichuk, Tung-Tien Sun, Anthony J Schaeffer, David J Klumpp
RESUMEN

Urinary tract infections are the second most common infectious disease in humans and are predominantly caused by uropathogenic E. coli (UPEC). A majority of UPEC isolates express the type 1 pilus adhesin, FimH, and cell culture and murine studies demonstrate that FimH is involved in invasion and apoptosis of urothelial cells. FimH initiates bladder pathology by binding to the uroplakin receptor complex, but the subsequent events mediating pathogenesis have not been fully characterized. We report a hitherto undiscovered signaling role for the UPIIIa protein, the only major uroplakin with a potential cytoplasmic signaling domain, in bacterial invasion and apoptosis. In response to FimH adhesin binding, the UPIIIa cytoplasmic tail undergoes phosphorylation on a specific threonine residue by casein kinase II, followed by an elevation of intracellular calcium. Pharmacological inhibition of these signaling events abrogates bacterial invasion and urothelial apoptosis in vitro and in vivo. Our studies suggest that bacteria-induced UPIIIa signaling is a critical mediator of bladder responses to insult by uropathogenic E. coli.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Estreptavidina−Peroxidasa from Streptomyces avidinii, lyophilized powder
Supelco
Casein Kinase II, Human, Recombinant, E. coli, Casein Kinase II, Human, Recombinant, E. coli Recombinant, is expressed in E. coli. A cyclic nucleotide-independent Ser/Thr protein kinase composed of catalytic α-subunits and regulatory β-subunits.
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Tnf
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Upk3a